Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cerebellum ; 21(3): 440-451, 2022 Jun.
Article in English | MEDLINE | ID: mdl-34390462

ABSTRACT

Recent studies suggest that the cerebellum may have a significant role in repetitive behaviors. In primary complex motor stereotypies, typically developing children have repetitive movements usually involving rhythmic flapping/waving arm/hand movements. Similarly, the deer mouse animal model exhibits inherited repetitive behaviors, with increased frequencies of spontaneous jumping and rearing. In this study, data from both children with motor stereotypies and deer mice were used to investigate the role of the cerebellum in repetitive behaviors. The 3.0-T MRI volumetric imaging of the cerebellum was obtained in 20 children with primary complex motor stereotypies and 20 healthy controls. In deer mice, cerebellar volume (n = 7/group) and cell counts (n = 9/group) were compared between high- and low-activity animals. Levels of cerebellar neurotransmitters were also determined via HPLC (n = 10/group). In children with stereotypies, (a) there were a statistically significant reduction (compared to controls) in the white matter volume of the posterior cerebellar lobule VI-VII that negatively correlated with motor control and (b) an 8% increase in the anterior vermis gray matter that positively correlated with motor Stereotypy Severity Scores (SSS). In deer mice, (a) there was a significant increase in the volume of the anterior vermal granular cell layer that was associated with higher activity and (b) dentate nucleus cell counts were higher in high activity animals. Similar increases in volume were observed in anterior vermis in children with stereotypies and a deer mouse model of repetitive behaviors. These preliminary findings support the need for further investigation of the cerebellum in repetitive behaviors.


Subject(s)
Peromyscus , Stereotyped Behavior , Animals , Cerebellum/diagnostic imaging , Cerebral Cortex , Child , Cognition , Humans
3.
Article in English | MEDLINE | ID: mdl-28589057

ABSTRACT

BACKGROUND: Sydenham's chorea (SC), the neurologic manifestation of rheumatic fever, remains the most prevalent form of chorea in children. Suggested treatments of chorea in SC include prophylactic penicillin, symptomatic (antipsychotic and anticonvulsant) medications, and immunomodulatory therapy (steroids, intravenous immunoglobulin (IVIG), and plasma exchange). In this manuscript, we undertook a systematic review of the published literature to examine the data supporting these therapeutic recommendations. METHODS: A search of PubMed, Embase, Psychinfo, and clinicaltrials.gov was conducted for publications pertaining to the treatment of SC/rheumatic chorea from 1956 to 2016. RESULTS: Penicillin prophylaxis appears to reduce the likelihood of further cardiac complications and the recurrence rate of chorea. Data on symptomatic therapy for chorea are limited to individual case reports or series and rare comparison studies. The efficacy of steroid use is supported by a single placebo-controlled study and several case series. Information on other immunomodulatory therapies such as IVIG and plasmapheresis are limited to a small number of reports and a single comparison study. DISCUSSION: Treatment decisions in SC are currently based on the treating physician's clinical experience, the desire to avoid side effects, and the existence of only limited scientific evidence. Based on a review of the available literature, chorea often improves with symptomatic therapy and immunotherapy tends to be reserved for those who fail to respond. Steroids are beneficial; however, data using IVIG and plasmapheresis are very limited. Larger, well-controlled studies, using standardized assessment scales, are required if therapeutic decisions for SC are to be based on meaningful information.

4.
Endocrinology ; 153(11): 5415-27, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23054057

ABSTRACT

Prostaglandins (PGs) are ubiquitous membrane-derived, lipid-signaling molecules with wide ranging effects throughout the body. In the brain, PGE(2) is the key regulator of fever after inflammation but is also implicated in neural development and synaptic plasticity. The steroid hormone estradiol is also a key regulator of neural development and synaptic plasticity. Recently, we showed that administering cyclooxygenase (COX) inhibitors to block PGE(2) production increased the total length of Purkinje cell dendrites, the number of dendritic spines, and the level of spinophilin protein, which is enriched in dendritic spines. Correspondingly, PGE(2) administration into the cerebellum decreased spinophilin protein content. We now report that PGE(2) stimulates estradiol synthesis in the immature rat cerebellum via enhanced activity of the aromatase enzyme. Treatment with cyclooxygenase inhibitors reduced cerebellar aromatase activity and estradiol content whereas PGE(2) administration increased both. Treatment with either PGE(2) or estradiol stunted Purkinje neuron dendritic length and complexity and produced a corresponding reduction in spinophilin content. Treatment with formestane to inhibit aromatase activity led to excessive sprouting of the dendritic tree, whereas elevated estradiol had the opposite effect. Electrophysiological measurements from Purkinje neurons revealed novel sex differences in input resistance and membrane capacitance that were abolished by estradiol exposure, whereas a sex difference in the amplitude of the afterhyperpolarization after an action potential was not. Correlated changes in action potential threshold suggest that prolonged alterations in neuronal firing activity could be a consequence of increased estradiol content during the second week of life. These findings reveal a previously unappreciated role for PG-stimulated steroidogenesis in the developing brain and a new potential route for inflammation-mediated disruption of neuronal maturation.


Subject(s)
Cerebellum/metabolism , Dendrites/metabolism , Dinoprostone/metabolism , Estradiol/biosynthesis , Action Potentials/drug effects , Action Potentials/physiology , Animals , Aromatase/metabolism , Cells, Cultured , Cerebellum/drug effects , Cyclooxygenase Inhibitors/pharmacology , Dendrites/drug effects , Dendritic Spines/drug effects , Dendritic Spines/metabolism , Dinoprostone/pharmacology , Estradiol/pharmacology , Female , Indomethacin/metabolism , Male , Microfilament Proteins/metabolism , Nerve Tissue Proteins/metabolism , Purkinje Cells/drug effects , Purkinje Cells/metabolism , Rats , Rats, Sprague-Dawley , Sulfonamides/pharmacology
5.
Eur J Neurosci ; 35(8): 1218-29, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22512254

ABSTRACT

Prostaglandins are lipid-derived molecules that mediate the generation of fever in the central nervous system. In addition to their proinflammatory role, prostaglandins also impact neuronal development and synaptic plasticity, sometimes in a sex-specific manner. The cerebellum has a high expression of prostaglandin receptors during development, but the role that these molecules play during normal cerebellar maturation is unknown. We demonstrate here that disrupting prostaglandin synthesis with cyclo-oxygenase inhibitors during a time-sensitive window in early postnatal life alters cerebellar Purkinje cell development in rats, resulting in initially increased dendritic growth in both sexes. We show that this results in later cerebellar atrophy in males only, resulting in a sex-specific loss of cerebellar volume. Further, although performance in motor tasks is spared, social interaction and the sensory threshold are altered in males developmentally exposed to cyclo-oxygenase inhibitors. This work demonstrates a previously unknown role for prostaglandins in cerebellar development and emphasizes the role that the cerebellum plays outside motor tasks, in cognitive and sensory domains that may help to explain its connection to complex neurodevelopmental disorders such as autism.


Subject(s)
Behavior, Animal/physiology , Cerebellum/growth & development , Cerebellum/metabolism , Dinoprostone/metabolism , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Behavior, Animal/drug effects , Cell Count , Cerebellum/cytology , Dendrites/drug effects , Dendrites/ultrastructure , Dinoprostone/antagonists & inhibitors , Dinoprostone/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Female , Injections, Intraventricular/methods , Injections, Subcutaneous , Male , Microfilament Proteins/metabolism , Nerve Tissue Proteins/metabolism , Organ Culture Techniques , Play and Playthings , Psychomotor Performance/drug effects , Psychomotor Performance/physiology , Purkinje Cells/cytology , Purkinje Cells/physiology , Rats , Regression Analysis , Sensory Thresholds/drug effects , Sensory Thresholds/physiology , Sex Factors , Silver Staining , Time Factors
6.
Trends Endocrinol Metab ; 21(9): 553-61, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20813326

ABSTRACT

Gonadal steroids organize the developing brain during a perinatal sensitive period and have enduring consequences for adult behavior. In male rodents testicular androgens are aromatized in neurons to estrogens and initiate multiple distinct cellular processes that ultimately determine the masculine phenotype. Within specific brain regions, overall cell number and dendritic morphology are the principal targets for hormonal organization. Recent advances have been made in elucidating the cellular mechanisms by which the neurological underpinnings of sexually dimorphic physiology and behavior are determined. These include estradiol-mediated prostaglandin synthesis, presynaptic release of glutamate, postsynaptic changes in glutamate receptors and changes in cell adhesion molecules. Sex differences in cell death are mediated by hormonal modulation of survival and death factors such as TNFalpha and Bcl-2/BAX.


Subject(s)
Brain/metabolism , Estradiol/metabolism , Sex Differentiation/physiology , Animals , Female , Gonadal Steroid Hormones/metabolism , Humans , Male
7.
Cerebellum ; 7(1): 38-47, 2008.
Article in English | MEDLINE | ID: mdl-18418672

ABSTRACT

Neurosteroids play an important role in the development of the cerebellum. In particular, estradiol and progesterone appear capable of inducing increases in dendritic spine density during development, and there is evidence that both are synthesized de novo in the cerebellum during critical developmental periods. In normal neonates and adults, there are few differences in the cerebellum between the sexes and most studies indicate that hormone and receptor levels also do not differ significantly during development. However, the sexes do differ significantly in risk of neuropsychological diseases associated with cerebellar pathology, and in animal models there are noticeable sex differences in the response to insult and genetic mutation. In both humans and animals, males tend to fare worse. Boys are more at risk for autism and Attention Deficit Hyperactivity Disorder than girls, and schizophrenia manifests at an earlier age in men. In rats males fare worse than females after perinatal exposure to polychlorinated biphenyls, and male mice heterozygous for the staggerer and reeler mutation show a more severe phenotype. Although very recent evidence suggests that differences in neurosteroid levels between the sexes in diseased animals may play a role in generating different disease phenotypes, the reason this hormonal difference occurs in diseased but not normal animals is currently unknown.


Subject(s)
Cerebellum/physiology , Estradiol/physiology , Progesterone/physiology , Animals , Cerebellum/embryology , Cerebellum/growth & development , Embryonic Development/physiology , Female , Humans , Male , Nervous System Diseases/psychology , Rodentia/growth & development , Rodentia/physiology , Sex Characteristics , Spinal Cord/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...